King Pharmaceuticals LLC
King Pharmaceuticals LLC, headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in the development and marketing of innovative therapeutic solutions. Founded in 1994, the company has achieved significant milestones, including strategic acquisitions that have expanded its portfolio and market reach. With a focus on pain management and other critical therapeutic areas, King Pharmaceuticals offers a range of unique products that address unmet medical needs. Their commitment to quality and innovation has positioned them as a trusted name in the healthcare sector. Notably, the company has garnered recognition for its contributions to patient care, solidifying its status as a leader in the pharmaceutical landscape.
DitchCarbon Score
How does King Pharmaceuticals LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
King Pharmaceuticals LLC's score of 45 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
King Pharmaceuticals LLC's reported carbon emissions
King Pharmaceuticals LLC, headquartered in the US, currently does not have publicly available data regarding its carbon emissions or specific climate commitments. Without emissions data, it is challenging to assess their environmental impact or track any reduction initiatives. The absence of documented reduction targets or commitments to frameworks such as the Science Based Targets Initiative (SBTi) suggests that the company may not have formalised its climate strategy at this time. As the pharmaceutical industry increasingly prioritises sustainability, it will be important for King Pharmaceuticals to establish clear climate commitments and emissions reduction goals to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
King Pharmaceuticals LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
